It will be interesting in the future to define the molecular basis of neutralisation by our Gc spike nanobodies, to determine whether they prevent infection by inhibiting a required conformational change, via steric hindrance of Lrp1 binding, or by preventing binding of an additional as-yet unidentified co-receptor. The gene discussed is LRP1; the disease is infection.